A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Hovedforfatter: | Islam, Nahidul |
---|---|
Andre forfattere: | Talukder, Mesbah |
Format: | Thesis |
Sprog: | English |
Udgivet: |
Brac University
2023
|
Fag: | |
Online adgang: | http://hdl.handle.net/10361/22025 |
Lignende værker
-
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
af: Afroza, Halima
Udgivet: (2024) -
Biologics and Biosimilars as Treatment Options for Psoriasis
af: Moya, Amena Khatun
Udgivet: (2023) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
af: Bishakha, Adwiza Chakraborty
Udgivet: (2024) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
af: Islam, S.M. Zahidul
Udgivet: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
af: Khandker, Tahia Anjum
Udgivet: (2024)